Trial Condition(s):
Prostate Cancer
Patient characteristics, treatment patterns, and resource usage among prostate cancer patients with bone metastasis in China
Bayer Identifier:
18324
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
The primary objectives of this study were to estimate the prevalence of both all prostate cancer and of prostate cancer with bone metastasis among urban employees in Beijing and Jinan from 2011 to 2014, and to described characteristics of those with bone metastasis. The secondary objective was to describe the common treatment pattern, resource use and treatment costs of prostate cancer patients with bone metastasis in Beijing and Jinan from 2011 to 2014.
Inclusion Criteria
- prostate cancer-related words were included in the diagnosis - the ICD-10 code was C61, C79.5 or M84.4 - the use of bisphosphonates or anti-tumor drugs, including radiation therapy drugs, chemotherapy drugs and endocrine drugs, was included in the medication administration record - surgery or radiation therapy was included in the medical record
Exclusion Criteria
- differential diagnosis, such as Osteoporosis, fracture need to be excluded
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations |
|---|
Trial Design
Patient characteristics, treatment patterns, and resource usage among prostate cancer patients with bone metastasis in China
Trial Type:
Observational
Intervention Type:
Other
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Prevalence of all prostate cancer and of prostate cancer with bone metastasisTimeframe: Retrospective analysis of four year period
- Caracteristics of patients with prostate cancer with bone metastasisTimeframe: Retrospective analysis of four year period
Secondary Outcome
- Treatment patterns of patients with prostate cancer and bone metastasisTimeframe: Retrospective analysis of four year period
- Costs of treatments used for patients with prostate cancer with bone metastasisTimeframe: Retrospective analysis of four year period
Additional Information
Copyright © Bayer
Powered by
